Dublin, Oct. 31, 2024 (GLOBE NEWSWIRE) -- The "CRISPR Technology Market" report has been added to ResearchAndMarkets.com's offering.
The CRISPR Technology Market was valued at USD 2024 in 2029, and is expected to reach USD 3.8 billion by 7.5 billion, rising at a CAGR of 14.4%.
This report on CRISPR technology provides market projections for 2029 and analyzes the market for CRISPR technology by application and end user. Applications covered include drug development, agriculture, diagnostics and others. End users include biotechnology and pharmaceutical companies, academics and government research institutes, and contract research organizations.
The report includes:
- 32 data tables and 61 additional tables
- An analysis of the global market for CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology
- Analyses of the global market trends, with data from 2021-2022, estimates for 2023, forecast for 2024, and projected CAGRs through 2029
- Discussion of the market potential for CRISPR technology
- Estimate of the market size and a revenue forecast for the global CRISPR technology market, and a corresponding market share analysis by application, end user, and region
- Discussion of the major market dynamics, regulations, industry challenges, and macroeconomic factors that will affect the demand for CRISPR technology market over the next five years
- A look at the recent breakthrough in CRISPR-Cas9 genome editing technology, and how it has propelled the rapid growth in genetic engineering and advanced pharmacological research
- A comparative study on CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion on its higher adaptability over other nucleases
- Review of the patent filings and research publications for innovations in the CRISPR-Cas9 genome editing technology
- A discussion on ESG challenges and ESG practices of the industry participants
- A look at the proprietary technologies and strategic alliances of the companies best positioned in the CRISPR market
- Analysis of the industry structure, competitive landscape, clinical trials, ongoing research activities, and the impact of COVID-19
- Company profiles of the major players in the CRISPR Technology Market including Merck, Thermo Fisher Scientific, Beam Therapeutics, CRISPR Therapeutics and Danaher.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 122 |
| Forecast Period | 2024 - 2029 |
| Estimated Market Value (USD) in 2024 | $3.8 Billion |
| Forecasted Market Value (USD) by 2029 | $7.5 Billion |
| Compound Annual Growth Rate | 14.4% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Genome Editing
- CRISPR
- Components of CRISPR
- Mechanism of Action
- CRISPR Gene Editing Workflow
- Advantages and Disadvantages of CRISPR Technology
- Pricing Analysis
- PESTLE Analysis
- Porter's Five Forces Analysis
- Regulatory Landscape, by Type
- Human
- Gene Drives
- Agriculture
- Animals
- Regulatory Landscape, by Region
Chapter 3 Market Dynamics
- Market Drivers
- Rising Incidence of Chronic Diseases
- Prevalence of Genetic Disorders
- Government and Private Funding
- Market Restraints
- Alternative Technologies
- Market Opportunities
- Increase in the Number of Applications
- Market Challenges
- Complex and Evolving Regulatory Landscape
- High Cost of CRISPR-based Therapy
Chapter 4 Emerging Technologies and Developments
- Emerging Technologies
- In Vivo Delivery of CRISPR
- Improved CAS Variants
- Artificial Intelligence
- Clinical Trials Analysis
- Clinical Trials Analysis, by Type of Study
- Clinical Trials Analysis, by Status
- Clinical Trials Analysis, by Phase
- Patent Analysis
- Patents, by Year
- Patents, by Top Applicant
- Patents, by Top Owner
- Patents, by Jurisdiction
- Intellectual Property Disputes and Patent Issues
Chapter 5 Market Segmentation Analysis
- Market Breakdown, by Application
- Drug Development
- Agriculture
- Diagnostics
- Other Applications
- Market Breakdown, by End User
- Biotech and Pharmaceutical Companies
- Academics and Government Research Institutes
- Contract Research Organizations
- Geographic Breakdown
Chapter 6 Competitive Intelligence
- Market Analysis
- Strategic Analysis
Chapter 7 Sustainability in CRISPR Technology: An ESG Perspective
- Sustainability in CRISPR Technology: An ESG Perspective
- Key ESG Issues
- CRISPR Technology ESG Performance Analysis
- Concluding Remarks
Company Profiles
- Agilent Technologies
- Beam Therapeutics
- Caribou Biosciences
- Crispr Therapeutics
- Danaher
- Editas Medicine
- Genscript
- Intellia Therapeutics
- Lonza
- Merck
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/r/sqyedx
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
